Unique ID issued by UMIN | UMIN000023398 |
---|---|
Receipt number | R000023120 |
Scientific Title | Multi-institutional Clinical Trial of Carbon-ion Radiotherapy for Peripherally located Inoperable Stage-I Non-small-cell Lung Cancer |
Date of disclosure of the study information | 2016/11/01 |
Last modified on | 2024/08/09 15:33:23 |
Multi-institutional Clinical Trial of Carbon-ion Radiotherapy for Peripherally located Inoperable Stage-I Non-small-cell Lung Cancer
Multi-institutional Clinical Trial of C-ion RT for Peripherally Stage-I NSCLC
Multi-institutional Clinical Trial of Carbon-ion Radiotherapy for Peripherally located Inoperable Stage-I Non-small-cell Lung Cancer
Multi-institutional Clinical Trial of C-ion RT for Peripherally Stage-I NSCLC
Japan |
Peripherally located inoperable stage-I non-small-cell lung cancer
Radiology |
Malignancy
NO
To evaluate efficacy and safety of Carbon-ion radiotherapy for peripherally located inoperable stage I non-small-cell lung cancer
Safety,Efficacy
Confirmatory
Pragmatic
3-year overall survival rate
Toxicities
Median survival time
2-year overall survival rate
2- and 3-year cause-specific survival rate
2- and 3-year progression-free survival rate
2- and 3-year local-progression-free rate
2- and 3-year local-progression-free survival rate
Pattern of recurrences
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment | Maneuver |
Carbon-ion radiotherapy
60.0GyRBE/4fractions (15.0GyRBE/fraction)
20 | years-old | <= |
90 | years-old | >= |
Male and Female
1)Pathologically confirmed or clinically diagnosed NSCLC
2)Clinically T1-T2aN0M0 diagnosed by imaging examinations including FDG-PET, and peripherally located
3)Considered to be unfit to lobar resection by cancer board including thoracic surgeon, pulmonary medical oncologist and radiation oncologist
4)Exist of lesion for evaluation
5)Initial treatment for the lesion
6)PS(ECOG) 0-2
7)SpO2 >= 90% or PaO2 >= 60 torr(mmHg)
8)FEV1.0 >= 700ml
9)>= 20 years-old / =< 90 years-old
10)Written informed consent
1)Severe comorbidities including infection and mental disorders
2) Interstitial pneumonitis on CT images
3)Coexisting malignancies within 2 years excepting Carcinoma in situ, stage-I laryngeal cancer, stage-I prostate cancer and stage-I breast cancer
4)History of thoracic irradiation
5)Pregnancy
6)Enrolled in other clinical trials with Interventions
7)Other reasons judged by physician
150
1st name | hiroaki |
Middle name | |
Last name | suefuji |
Ion Beam Therapy Center, SAGA-HIMAT Foundation
Department of Radiation Oncology
841-0071
3049 Harakoga-machi, Tosu, Japan
0942-81-1897
sufg@saga-himat.jp
1st name | hiroaki |
Middle name | |
Last name | suefuji |
Ion Beam Therapy Center, SAGA-HIMAT Foundation
Department of Radiation Oncology
841-0071
3049 Harakoga-machi, Tosu, Japan
0942-81-1897
1501lung@saga-himat.jp
Ion Beam Therapy Center, SAGA-HIMAT Foundation
National Institute of Radiological Sciences
Other
Ion Beam Therapy Center, SAGA-HIMAT Foundation Institutional Review Board
3049 Harakoga-machi, Tosu, Japan
0942-81-1897
saga-himat@saga-himat.jp
YES
J-CROS 1501 LUNG
Japan Carbon-ion Radiation Oncology Study Group
九州国際重粒子線がん治療センター(佐賀県)、QST病院(千葉県)、群馬大学重粒子医学研究センター(群馬県)、兵庫県立粒子線医療センター(兵庫県)、神奈川県立がんセンター(神奈川県)、大阪重粒子線センター(大阪府)、山形大学医学部附属病院(山形県)
2016 | Year | 11 | Month | 01 | Day |
Unpublished
56
No longer recruiting
2016 | Year | 04 | Month | 05 | Day |
2023 | Year | 10 | Month | 26 | Day |
2016 | Year | 11 | Month | 01 | Day |
2027 | Year | 06 | Month | 30 | Day |
2016 | Year | 07 | Month | 29 | Day |
2024 | Year | 08 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023120